Treatment of cerebral edema: present and future
- Авторлар: Gudkova V.V.1, Kimelfeld E.I1, Prikhodko E.V2, Koltsova E.A1, Stakhovskaya L.V1
-
Мекемелер:
- Pirogov Medical University
- Hospital for War Veterans № 3
- Шығарылым: Том 28, № 3 (2021)
- Беттер: 18-24
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/313098
- DOI: https://doi.org/10.18565/pharmateca.2021.3.18-24
- ID: 313098
Дәйексөз келтіру
Аннотация
Толық мәтін
Авторлар туралы
Valentina Gudkova
Pirogov Medical University
Email: gudkova.valentina@gmail.com
Cand. Sci. (Med.), Professor at the Department of Neurology, Neurosurgery and Medical Genetics Moscow, Russia
E. Kimelfeld
Pirogov Medical UniversityMoscow, Russia
E. Prikhodko
Hospital for War Veterans № 3Moscow, Russia
E. Koltsova
Pirogov Medical UniversityMoscow, Russia
L. Stakhovskaya
Pirogov Medical UniversityMoscow, Russia
Әдебиет тізімі
- Царенко С.В., Дзядзько А.М., Рыбалко С.С. Глибенкламид - перспективное средство профилактики и лечения отека головного мозга. Вопросы нейрохирургии им. Н.Н. Бурденко. 2017;3:88-93
- Jha R.M, Kochanek P.M., Simard J.M. Pathophysiology and treatment of cerebral edema in traumatic brain injury. Neuropharmacol. 2019;145(B):230-46. doi: 10.1016/j.neuropharm.2018.08.004.
- Michinaga S., Koyama Y. Pathogenesis of Brain Edema and Investigation into Anti-Edema Drugs. Int J Mol Sci. 2015;16:9949-75. doi: 10.3390/ijms16059949.
- Stokum J.A, Gerzanich V, Simard J.M. Molecular pathophysiology of cerebral edema. J. Cerebral Blood Flow Metabol. 2016;36(3):513-38. doi: 10.1177/0271678x15617172.
- Задворнов А.А., Голомидов А.В., Григорьев Е.В. Клиническая патофизиология отека головного мозга (часть 2). Вестник анестезиологии и реаниматологии. 2017;14(4):52-60.
- Carney N., Totten A.M., O'Reilly C., et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Neurosurg. 2017;80:6-15. doi: 10.1227/neu.0000000000001432
- Powers W.J., Rabinstein A.A., Ackerson T., et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/ AmericanStrokeAssociation. Stroke. 2018;49(3):46-110. doi: 10.1161/str.0000000000000158.
- Геморрагический инсульт. Обновленные клинические рекомендации. М., 2020 Разработчики: Ассоциация нейрохирургов России, Всероссийское общество неврологов, Ассоциация анестезиологов и реаниматологов России, Ассоциация реабилитологов России.
- Солодов А.А., Петриков С.С. Гиперосмолярные растворы в комплексе лечения больных с внутричерепными кровоизлияниями. Вестник интенсивной терапии. 2009;2:22-32
- Maguigan K.L., Dennis B.M., Hamblin S.E., et al. Method of Hypertonic Saline Administration: Effects on Osmolality in Traumatic Brain Injury Patients. J Clin Neurosci. 2017;39:147-50. Doi: 10.1016/j. jocn.2017.01.025.
- Alnemari A.M., Krafcik B.M., Mansour T.R., et al. A comparison of pharmacologic therapeutic agents used for the reduction of intracranial pressure after traumatic brain injury. World Neurosurgery. 2017;106:509-28. Doi: 10.1016/j. wneu.2017.07.009.
- Peters N.A., Farrell L.B., Smith J.P Hyperosmolar Therapy for the Treatment of Cerebral Edema. US Pharm. 2018:43(1) HS-8-HS-11. https://www. uspharmacist.com
- Галушко А.А., Богдан А.М. Дискусійні питання застосування манітолу у хворих на гострий інсульт (огляд літератури й власний досвід). Медицина неотложных состояний. 2018;89(2):23-8.
- Mangat H.S., Wu X., Gerber L.M., et al. Hypertonic Saline is Superior to Mannitol for the Combined Effect on Intracranial Pressure and Cerebral Perfusion Pressure Burdens in Patients With Severe Traumatic Brain Injuiy. Neurosurg. 2020;86(2):221-30. doi: 10.1093/neuros/nyz046.
- Мартынов В. А., Жданович Л. Г, Карасева Е. А. и др. Отек-набухание головного мозга: тактика ведения больных. Инфекционные болезни: новости, мнения, обучение. 2018;7(1):124-31.
- URL: https://www.vidal.ru/drugs/mannitol 5246
- Основы интенсивной терапии. Руководство Всемирной федерации общества анестезиологов (WFSA). Главный ред.: Б. Маккормик, ред. русского издания: В.В. Кузьков, Э.В. Недашковский. 2-е изд., перераб. и допол. 2016
- Lin S.-Y., Tang S.-C., Tsai L.-K., et al. Incidence and risk factors for acute kidney Injury following Mannitol infusion in patients with acute stroke: a retrospective cohort study. Med. (Baltimore). 2015;94(47): e2032. doi: 10.1097/md.0000000000002032.
- Garcfa-Morales E.J., Cariappa R., Parvin C.A., et al. Osmole gap in neurologic-neurosurgical intensive care unit: Its normal value, calculation, and relationship with mannitol serum concentrations. Critical Care Med. 2004;32(4):986-91. doi: 10.1097/01. ccm.0000120057.04528.60.
- Brouwer M.C., McIntyre P, Prasad K., et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12;2015(9):CD004405. doi: 10.1002/14651858. cd004405.pub5.
- Prasad K., Singh M.B., Ryan H. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2016 Apr 28;4(4):CD002244. doi: 10.1002/14651858.cd002244.pub4.
- De Gans J., van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002;34 7(20): 1549-56. Doi: 10.1056/ nejmoa021334.
- Powers W.J., Rabinstein A.A., Ackerson T., et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/ American Stroke Association. Stroke. 2019;50(12). doi: 10.1161/str.0000000000000211.
- Ишемический инсульт и транзиторная ишемическая атака у взрослых. Клинические рекомендации. М., 2015
- Hawryluk G.W.J., Rubiano A.M., Totten A.M., et al. Guidelines for the Management of Severe Traumatic Brain Injury: 2020 Update of the Decompressive Craniectomy Recommendations. Neurosurg. 2020;87(3):427-34. doi: 10.1093/neuros/ nyaa278.
- Abdelmalik P.A., Draghic N., Ling G.S.F. Management of moderate and severe traumatic brain injury. Transfus. 2019;59(Suppl. 2):1529-38. doi: 10.1111/trf.15171.
- Горбачев В.И., Брагина Н.В., Горбачев С.В. О взаимосвязи внутричерепного давления и кровотока при позиционировании у больных с острым повреждением головного мозга. Регионарное кровообращение и микроциркуляция. 2019;18(4):4- 10.
- Отек головного мозга. Рассмотрение патофизиологических механизмов на основе системного подхода. 5-й Тбилисский симпозиум по мозговому кровообращению, 20-23 апреля 1983 г. Сост. и ред. Г.И. Мчедлишвили. Тбилиси, 1986. 176 с
- Simard J.M., Kent T.A., Chen M., et ai. Brain oedema in focai ischaemia: moiecuiar pathophysiology and theoreticai impiications. Lancet Neuroi. 2007;6(3):258-68. doi: 10.1016/s1474-4422(07)70055-8.
- King Z.A., Sheth K.N., Kimberiy W.T., et ai. Profiie of intravenous giyburide for the prevention of cerebrai edema foiiowing iarge hemispheric infarction: evidence to date. Drug Design Devei Ther. 2018;12:2539-52. doi: 10.2147/dddt.s150043.
- Luo Z.-W., Ovcjak A., Wong R., et ai. Drug deveiopment in targeting ion channeis for brain edema. Acta Pharmacoi Sinica. 2020;41(10):1272-88. doi: 10.1038/s41401-020-00503-5.
- Robert S.M., Reeves B.C., Aiper S.L., et ai. New drugs on the horizon for cerebrai edema: what's in the ciinicai deveiopment pipeiine? Exp Opin Invest Drugs. 202;29(10):1099-105. doi: 10.1080/13543784.2020.1813715.
- Simard J.M, Chen M., Tarasov K.V., et ai. Newiy expressed SUR1-reguiated NCCa-ATP channei mediates cerebrai edema after ischemic stroke. Nat Med. 2006;12(4):433-40. doi: 10.1038/nm1390.
- Kahie K.T., Simard J.M., Staiey K.J., et ai. Moiecuiar mechanisms of ischemic cerebrai edema: roie of eiectroneutrai ion transport. Physioi. 2009;24:257-doi: 10.1152/physioi.00015.2009.
- Zafardoost P, Ghasemi A.A., Saiehpour F., et ai. Evaiuation of the effect of glibenciamide in patients with diffuse axonal injury due to moderate to severe head trauma. Trauma Monthiy. 2016;21(5):e25113. doi: 10.5812/traumamon.25113.
- Khalili H., Derakhshan N., Niakan A., et ai. Effects of oral glibenciamide on brain contusion volume and functional outcome of patients with moderate and severe traumatic brain injuries: a randomized doubie-biind piacebo-controiied ciinical trial. Worid Neurosurg. 2017;101:130-36. Doi: 10.1016/j. wneu.2017.01.103.
- Jha R.M., Beli J., Citerio G., et al. Roie of Suifonyiurea Receptor 1 and Glibenciamide in Traumatic Brain Injury. Review of the Evidence. Int J Mol Sci. 2020;21(2): 409. doi: 10.3390/ijms21020409.
- Simard J.M., Woo S., Tsymbalyuk N., et ai. Glibenciamide-10-h Treatment Window in a Clinicaily Relevant Model of Stroke. Transiational Stroke Res. 2012;3(2):286-95. doi: 10.1007/s12975-012-0149-x.
- Kunte H., Schmidt S., Eliasziw M., et al. Suifonyiureas Improve Outcome in Patients With Type 2 Diabetes and Acute Ischemic Stroke. Stroke. 2007;38(9):2526-
- doi: 10.1161/strokeaha.107.482216.
- Аметов А.С., Кондратьева Л.В. Возможности клинического применения глибенкламида в XXI в. Эндокринология: новости, мнения, обучение. 2017.4:33-43
- Caffes N., Kuriand D.B., Gerzanich V, et al. Glibenciamide for the treatment of ischemic and hemorrhagic stroke. Review. Int J Mol Sci. 2015;16(3):4973-84. Doi: 10.3390/ ijms16034973.
- Sheth K.N., Kimberly W.T., Eim J.J., et al. Pilot Study of Intravenous Glyburide in Patients With a Large Ischemic Stroke. Stroke. 2014;45(1):281-83. doi: 10.1161/strokeaha.113.003352
- Heth K.N., Kimberly W.T., Eim J.J., et al. Exploratory Analysis of Giyburide as a Novei Therapy for Preventing Brain Swelling. Neurocritical Care. 2014;21(1):43-51. doi: 10.1007/s12028-014-9970-2.
- Sheth K.N., Eim J.J., Besiow L.A., et al. Giyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial: Rationaie and Design. Neurocritical Care. 2016;24(1):132-39. doi: 10.1007/s12028-015-0189-7.
- Sheth K.N., Eim J.J., Molyneaux B.J., et al. Safety and efficacy of intravenous glyburide on brain swelling after iarge hemispheric infarction (GAMES-RP): a randomised, double-biind, placebo-controiied phase 2 trial. Lancet Neurol. 2016;15(11):1160-69. doi: 10.1016/s1474-4422(16)30196-x.
- Sheth K.N., Petersen N.H., Cheung K., et al. Long-Term Outcomes in Patients Aged ≤70 Years With Intravenous Giyburide From the Phase II GAMES-RP Study of Large Hemispheric Infarction: An Expioratory Anaiysis. Stroke. 2018;49(6):1457-63. doi: 10.1161/strokeaha.117.020365.
- Kimberly W.T., Bevers M.B., von Kummer R., et al. Effect of IV glyburide on adjudicated edema endpoints in the GAMES-RP Trial. Neuroi. 2018;91(23):e2163-doi: 10.1212/wni.0000000000006618.
- Pailan T.V., Ahmed I. Giyburide in Treating Maiignant Cerebral Edema. Blocking Suifonyl Urea One (SUR1) Receptors. J Vascular Intervent Neuroi. 2014;7(4):23-5.
- Geiseler S.J., Moriand C. The Janus Face of VEGF in Stroke. Int J Moi Sci. 2018;19(5):1362. doi: 10.3390/ijms19051362.
- Piazza M., Munasinghe J., Murayi R., et al. Simulating vasogenic brain edema using chronic VEGF infusion. J Neurosurg. 2017;127(4):905-16. doi: 10.3171/2016.9.jns1627.
- Tourdias T., Mori N., Dragonu I., et al. Differential aquaporin 4 expression during edema build-up and resolution phases of brain inflammation. J Neuroinflammat. 2011;8:143. Doi: 10.1186/ 1742-2094-8-143.